 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > 3-Dimensional Pharmaceuticals, Inc.
 |
3-Dimensional Pharmaceuticals, Inc. |
 |
 |
 |
PROFILE |
 |
3-Dimensional Pharmaceuticals is adding a fourth dimension to drug discovery -- timeliness. The biotech firm's DiscoverWorks technology identifies drug candidates by using such features as target protein production, high-throughput screening, a library of some 200,000 chemical compounds and 2.5 billion novel analogs, and 3-D protein structure analysis to expedite the process. In addition to licensing its technology to such partners as DuPont, Aventis, and Bristol-Myers Squibb, 3-Dimensional is developing a pipeline of cardiovascular and oncology drug candidates, which it plans to license out in the early trial stages. HealthCare Ventures owns almost a quarter of the company.
COMPETITION |
 |
Aurora Biosciences Corporation (dossier)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 12.40
1-Yr. Sales Growth: 176.2%
Employees: 140
Revenue per employee: $88,571.43
KEY PEOPLE |
 |
David C. U'Prichard
CEO
CONTACT INFO |
 |
Eagleview Corporate Center, Ste. 104,
Exton, PA 19341
US
Phone: 610-458-8959
Fax: 610-458-8249
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |